{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:26:14Z","timestamp":1780932374510,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2024 Guangxi Doctoral Innovation Project","award":["YCBZ2024128"],"award-info":[{"award-number":["YCBZ2024128"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02190-9","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:06:28Z","timestamp":1773140788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apolipoprotein D downregulation in OSCC: multi-database validation and clinical significance"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2464-2235","authenticated-orcid":false,"given":"Shuting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-9057","authenticated-orcid":false,"given":"Xiaolin","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2190_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.12688\/f1000research.22941.1","volume":"9","author":"A Bugshan","year":"2020","unstructured":"Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Res. 2020;9:229.","journal-title":"F1000Res"},{"issue":"5","key":"2190_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"2190_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4\u201322.","journal-title":"Br J Cancer"},{"issue":"3","key":"2190_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2018.02.097","volume":"504","author":"M Maan","year":"2018","unstructured":"SVENSSON R U, PARKER S J, EICHNER L J, et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models[J]. Nature Medicine. 2016;22(9):1108\u20131119.","journal-title":"Biochem Biophys Res Commun"},{"key":"2190_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in Cancer cells supporting enhanced growth and proliferation. Cells. 2021;10:1056.","journal-title":"Cells"},{"key":"2190_CR6","doi-asserted-by":"crossref","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev, 2014, 2014: 360438.","DOI":"10.1155\/2014\/360438"},{"issue":"6","key":"2190_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4103\/1735-3327.197036","volume":"13","author":"AV Reddy","year":"2016","unstructured":"Reddy AV, Killampalli LK, Prakash AR, et al. Analysis of lipid profile in cancer patients, smokers, and nonsmokers. Dent Res J (Isfahan). 2016;13(6):494\u20139.","journal-title":"Dent Res J (Isfahan)"},{"issue":"4\u20136","key":"2190_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000086977","volume":"68","author":"M Notarnicola","year":"2005","unstructured":"Notarnicola M, Altomare DF, Correale M, et al. Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology. 2005;68(4\u20136):371\u20134.","journal-title":"Oncology"},{"issue":"11","key":"2190_CR9","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12094-020-02354-2","volume":"22","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Luo G. Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer. Clin Transl Oncol. 2020;22(11):1952\u201362.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"2190_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12885-020-6679-9","volume":"20","author":"JU Onwuka","year":"2020","unstructured":"Onwuka JU, Okekunle AP, Olutola OM, et al. Lipid profile and risk of ovarian tumours: a meta-analysis. BMC Cancer. 2020;20(1):200.","journal-title":"BMC Cancer"},{"key":"2190_CR11","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.molmet.2022.101600","volume":"65","author":"X Chen","year":"2022","unstructured":"Chen X, Liu Q, Chen Y, et al. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma. Mol Metab. 2022;65:101600.","journal-title":"Mol Metab"},{"key":"2190_CR12","first-page":"703","volume":"45","author":"M Ayrault Jarrier","year":"1963","unstructured":"Ayrault Jarrier M, Levy G, Polonovski J. [Study of humanserum Alpha-Lipoproteins by immunoelectrophoresis]. Bull Soc Chim Biol (Paris). 1963;45:703\u201313.","journal-title":"Bull Soc Chim Biol (Paris)"},{"key":"2190_CR13","first-page":"144874","volume":"756","author":"E Rassart","year":"2020","unstructured":"Rassart E, Desmarais F, Najyb O, et al. Apolipoprotein D Gene. 2020;756:144874.","journal-title":"Apolipoprotein D Gene"},{"issue":"1","key":"2190_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ijc.20986","volume":"116","author":"T Utsunomiya","year":"2005","unstructured":"Utsunomiya T, Ogawa K, Yoshinaga K, et al. Clinicopathologic and prognostic values of Apolipoprotein D alterations in hepatocellular carcinoma. Int J Cancer. 2005;116(1):105\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"2190_CR15","first-page":"417","volume":"27","author":"K Ogawa","year":"2005","unstructured":"Ogawa K, Utsunomiya T, Mimori K, et al. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application. Int J Oncol. 2005;27(2):417\u201326.","journal-title":"Int J Oncol"},{"issue":"3","key":"2190_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1006\/gyno.1999.5678","volume":"76","author":"J V\u00e1zquez","year":"2000","unstructured":"V\u00e1zquez J, Gonz\u00e1lez L, Merino A, et al. Expression and clinical significance of Apolipoprotein D in epithelial ovarian carcinomas. Gynecol Oncol. 2000;76(3):340\u20137.","journal-title":"Gynecol Oncol"},{"key":"2190_CR17","doi-asserted-by":"crossref","unstructured":"Ruchong P, Haiping T, Xiang W. A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer. Dis Markers, 2021, 2021: 5510780.","DOI":"10.1155\/2021\/5510780"},{"issue":"17","key":"2190_CR18","doi-asserted-by":"publisher","first-page":"29487","DOI":"10.18632\/oncotarget.15494","volume":"8","author":"ME Monaco","year":"2017","unstructured":"Monaco ME. Fatty acid metabolism in breast cancer subtypes. Oncotarget. 2017;8(17):29487\u2013500.","journal-title":"Oncotarget"},{"issue":"1","key":"2190_CR19","doi-asserted-by":"publisher","first-page":"e20201606","DOI":"10.1084\/jem.20201606","volume":"218","author":"X Bian","year":"2021","unstructured":"Bian X, Liu R, Meng Y, et al. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.","journal-title":"J Exp Med"},{"issue":"16","key":"2190_CR20","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1002\/cam4.2587","volume":"8","author":"L Ren","year":"2019","unstructured":"Ren L, Yi J, Li W, et al. Apolipoproteins and cancer. Cancer Med. 2019;8(16):7032\u201343.","journal-title":"Cancer Med"},{"issue":"10","key":"2190_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield LA, Pane AA, Talebi A, et al. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363\u201393.","journal-title":"Dev Cell"},{"issue":"1\u20132","key":"2190_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0167-4838(00)00162-X","volume":"1482","author":"E Rassart","year":"2000","unstructured":"Rassart E, Bedirian A, Do Carmo S, et al. Apolipoprotein D. Biochim Biophys Acta. 2000;1482(1\u20132):185\u201398.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"2190_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0167-4781(93)90292-L","volume":"1172","author":"J Lambert","year":"1993","unstructured":"Lambert J, Provost PR, Marcel YL, et al. Structure of the human Apolipoprotein D gene promoter region. Biochim Biophys Acta. 1993;1172(1\u20132):190\u20132.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2190_CR24","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1074\/jbc.M105057200","volume":"277","author":"S Do Carmo","year":"2002","unstructured":"Do Carmo S, S\u00e9guin D, Milne R, et al. Modulation of Apolipoprotein D and Apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem. 2002;277(7):5514\u201323.","journal-title":"J Biol Chem"},{"issue":"4","key":"2190_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1194\/jlr.M300312-JLR200","volume":"45","author":"S Hummasti","year":"2004","unstructured":"Hummasti S, Laffitte BA, Watson MA, et al. Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apod as a direct target. J Lipid Res. 2004;45(4):616\u201325.","journal-title":"J Lipid Res"},{"issue":"6","key":"2190_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bbamcr.2007.03.007","volume":"1773","author":"S Do Carmo","year":"2007","unstructured":"Do Carmo S, Levros LC Jr., Rassart E. Modulation of Apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta. 2007;1773(6):954\u201369.","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"2190_CR27","first-page":"4336","volume":"51","author":"J Simard","year":"1991","unstructured":"Simard J, Veilleux R, de Launoit Y, et al. Stimulation of Apolipoprotein D secretion by steroids coincides with Inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res. 1991;51(16):4336\u201341.","journal-title":"Cancer Res"},{"issue":"23","key":"2190_CR28","first-page":"6189","volume":"47","author":"OA Lea","year":"1987","unstructured":"Lea OA, Kvinnsland S, Thorsen T. Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res. 1987;47(23):6189\u201392.","journal-title":"Cancer Res"},{"issue":"14","key":"2190_CR29","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1096\/fj.03-0053rev","volume":"17","author":"M Romano","year":"2003","unstructured":"Romano M, Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. Faseb J. 2003;17(14):1986\u201395.","journal-title":"Faseb J"},{"issue":"1","key":"2190_CR30","first-page":"73","volume":"14","author":"M Matsuyama","year":"2005","unstructured":"Matsuyama M, Yoshimura R, Mitsuhashi M, et al. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep. 2005;14(1):73\u20139.","journal-title":"Oncol Rep"},{"issue":"1","key":"2190_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.28340","volume":"134","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Xu X, Yuan Y, et al. IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus. Int J Cancer. 2013;134(1):224\u201334.","journal-title":"Int J Cancer"},{"issue":"1","key":"2190_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2016.07.080","volume":"478","author":"R Wang","year":"2016","unstructured":"Wang R, Davidoff AM, Pfeffer LM. Bortezomib sensitizes human glioblastoma cells to induction of apoptosis by type I interferons through NOXA expression and Mcl-1 cleavage. Biochem Biophys Res Commun. 2016;478(1):128\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2190_CR33","doi-asserted-by":"publisher","first-page":"e007625","DOI":"10.1136\/jitc-2023-007625","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Han X, Sun M, et al. Caspase-9 Inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity. J Immunother Cancer. 2023;11(12):e007625.","journal-title":"J Immunother Cancer"},{"key":"2190_CR34","doi-asserted-by":"crossref","unstructured":"Streck CJ, Ng CY, Zhang Y et al. Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett, 2005, 228(1\u20132): 163\u2009\u2013\u200970.","DOI":"10.1016\/j.canlet.2004.11.063"},{"issue":"2","key":"2190_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/scbi.2000.0311","volume":"10","author":"C Prejean","year":"2000","unstructured":"Prejean C, Colamonici OR. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin Cancer Biol. 2000;10(2):83\u201392.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2190_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jmb.2004.05.059","volume":"341","author":"P Lamken","year":"2004","unstructured":"Lamken P, Lata S, Gavutis M, et al. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J Mol Biol. 2004;341(1):303\u201318.","journal-title":"J Mol Biol"},{"issue":"9","key":"2190_CR37","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1110\/ps.8.9.1867","volume":"8","author":"RM Arduini","year":"1999","unstructured":"Arduini RM, Strauch KL, Runkel LA, et al. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains. Protein Sci. 1999;8(9):1867\u201377.","journal-title":"Protein Sci"},{"issue":"710","key":"2190_CR38","doi-asserted-by":"publisher","first-page":"eabe4627","DOI":"10.1126\/scisignal.abe4627","volume":"14","author":"M Shemesh","year":"2021","unstructured":"Shemesh M, Lochte S, Piehler J, et al. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating stats. Sci Signal. 2021;14(710):eabe4627.","journal-title":"Sci Signal"},{"issue":"863","key":"2190_CR39","doi-asserted-by":"publisher","first-page":"eadl1892","DOI":"10.1126\/scisignal.adl1892","volume":"17","author":"E Zoler","year":"2024","unstructured":"Zoler E, Meyer T, Bell\u00f3n JS, et al. Promiscuous Janus kinase binding to cytokine receptors modulates signaling efficiencies and contributes to cytokine Pleiotropy. Sci Signal. 2024;17(863):eadl1892.","journal-title":"Sci Signal"},{"key":"2190_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2190_CR41","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/ph3040994","volume":"3","author":"J Bekisz","year":"2010","unstructured":"Bekisz J, Baron S, Balinsky C, et al. Antiproliferative properties of type I and type II interferon. Pharmaceuticals (Basel). 2010;3(4):994\u20131015.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"2190_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/icb.2012.13","volume":"90","author":"NE Mangan","year":"2012","unstructured":"Mangan NE, Fung KY. Type I interferons in regulation of mucosal immunity. Immunol Cell Biol. 2012;90(5):510\u20139.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"2190_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jss.2010.09.044","volume":"173","author":"RF Saidi","year":"2012","unstructured":"Saidi RF, Ahad A, Tilak J, et al. The expression of interferon receptor \u03b1\/\u03b2 in human pancreatic cancer in nude mice is essential for tumor response to interferon \u03b1 treatment. J Surg Res. 2012;173(2):309\u201313.","journal-title":"J Surg Res"},{"issue":"3","key":"2190_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/jcmm.12200","volume":"18","author":"S Booy","year":"2014","unstructured":"Booy S, van Eijck CH, Dogan F, et al. Influence of type-I interferon receptor expression level on the response to type-I interferons in human pancreatic cancer cells. J Cell Mol Med. 2014;18(3):492\u2013502.","journal-title":"J Cell Mol Med"},{"issue":"32","key":"2190_CR45","doi-asserted-by":"publisher","first-page":"52115","DOI":"10.18632\/oncotarget.10313","volume":"7","author":"O Danziger","year":"2016","unstructured":"Danziger O, Shai B, Sabo Y, et al. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection. Oncotarget. 2016;7(32):52115\u201334.","journal-title":"Oncotarget"},{"issue":"52","key":"2190_CR46","doi-asserted-by":"publisher","first-page":"13792","DOI":"10.1073\/pnas.1713728114","volume":"114","author":"MR Doherty","year":"2017","unstructured":"Doherty MR, Cheon H, Junk DJ, et al. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc Natl Acad Sci U S A. 2017;114(52):13792\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2190_CR47","doi-asserted-by":"publisher","first-page":"1860477","DOI":"10.1080\/2162402X.2020.1860477","volume":"10","author":"CC Qiu","year":"2020","unstructured":"Qiu CC, Kotredes KP, Cremers T, et al. Targeted Stat2 deletion in conventional dendritic cells impairs CTL responses but does not affect antibody production. Oncoimmunology. 2020;10(1):1860477.","journal-title":"Oncoimmunology"},{"issue":"2","key":"2190_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/jpm12020140","volume":"12","author":"YC Huang","year":"2022","unstructured":"Huang YC, Huang JL, Tseng LC, et al. High expression of interferon pathway genes CXCL10 and STAT2 is associated with activated T-Cell signature and better outcome of oral Cancer patients. J Pers Med. 2022;12(2):140.","journal-title":"J Pers Med"}],"updated-by":[{"DOI":"10.1186\/s12920-026-02404-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000}}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02190-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:02:26Z","timestamp":1780905746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02190-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02190-9","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: The last author is the sole corresponding author.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12920-026-02404-8","URL":"https:\/\/doi.org\/10.1186\/s12920-026-02404-8","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Hospital of Stomatology, Guangxi Medical University (No. 2024070), and any research pertaining to human use has been conducted in accordance with the Declaration of Helsinki\u2019s tenets and all applicable institutional and national regulations. The present study of paraffin tissues applied for IHC detection was retrospective in nature and was approved by the Institutional Review Board (IRB) of the Ethics Committee of the Hospital of Stomatology, Guangxi Medical University, with a waiver of informed consent. Informed consent was obtained from all patients for tissues used for qRT-PCR. All participants information is reasonably protected and unidentified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}